FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: Bristol-Myers Squibb Company

Sort
E.g., 2013-05-22
E.g., 2013-05-22
Enter a comma separated list of user names.

The Bank of New York Mellon Corporation (NYSE:BK) previously announced that Marina Lewin has been named head of Global Sales and that Steve Farlese has been named head of Global Service Delivery. Both are new positions within the business. Lewin and Farlese will continue to be based in New York City and report to Brian Ruane, BNY Mellon AIS chief executive officer.

Proteonomix, Inc. (PROT.OB) is a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives.

PROT recently reported further developments with its Joint Venture Company, XGEN Medical LLC (”XGen”) towards implementing operations in the United Arab Emirates.

Bristol-Myers Squibb

Posted by tobylang on May 24th, 2009

This week we are reviewing Bristol-Myers Squibb as a possible stock acquisition. To do so we will use the Buffett four filters we discussed in a previous article.

ADVERTISE WITH US